D eng Wen is a Chinese entrepreneur who is the chairman of Kexing Biopharm, a pharmaceutical company specializing in the research, development, and production of protein-based drugs. He has built his fortune in the high-tech biopharmaceutical sector, focusing on creating treatments for a variety of critical illnesses.

Kexing Biopharm is a leader in producing drugs based on recombinant proteins, which are used to treat conditions in areas like oncology, immunology, and hematology. Under Deng's leadership, the company has become a significant player in China's domestic biopharma market. The company is listed on Shanghai's tech-focused STAR Market, and Deng's wealth is derived from his large stake in the successful biotechnology firm he leads.